• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • NORTH AMERICA EDITION
      Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • NORTH AMERICA EDITION
      North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Cannabis Market
    Cannabis News
    Cannabis Stocks
    • Cannabis Market
    • Cannabis News
    • Cannabis Stocks
    cannabis investing

    Medipure Files Provisional Patent for Cannabinoid-based Pain Management Product

    Kristen Moran
    Jun. 30, 2015 11:30AM PST
    Cannabis Investing News

    Medipure Holdings Inc. (CSE:MDH) announced that its subsidiary, Medipure Pharmaceuticals Inc. has filed a provisional patent application for a therapeutic, cannabinoid-based formulation for pain management, which is the base of Medipure’s MP-10X product line.

    Medipure Holdings Inc. (CSE:MDH) announced that its subsidiary, Medipure Pharmaceuticals Inc. has filed a provisional patent application for a therapeutic, cannabinoid-based formulation for pain management, which is the base of Medipure’s MP-10X product line.

    As quoted in the press release:

    On June 15, 2015, Medipure announced that it had filed a provisional patent application for a cannabinoid-based formulation designed to treat anxiety.

    A provisional patent application is a legal document that establishes an early priority date for the benefit of claiming “first to file” status against other companies or individuals that may want to file for a patent with similar claims after the filing date of Medipure’s provisional application.

    Boris Weiss, CEO of Medipure, commented:

    We are very pleased to formally file this provisional patent, our second in the span of two weeks. Like our earlier filing, this second addition to our portfolio of intellectual property serves to highlight the considerable potential of our research and development efforts. Furthermore, we have now filed patent applications regarding the formulations that make up the foundation of both of our intended initial commercial offerings.

    According to Global Industry Analysts, the global market for pain management is expected to reach US $60 billion this year, making it one of the largest segments of the pharmaceutical industry. More than 1.5 billion people suffer from chronic pain, while approximately 3% to 4.5% of the global population suffer from neuropathic pain. However, many currently available pain medications can present unwanted side effects or dependency issues. Our cannabinoid-based medications are intended to create safe, effective alternatives that either mitigate or eliminate these challenges. I am excited to continue moving both MP-10X and MP-20X towards production, and to the benefits they will provide for both patients and doctors.

    Click here to read the full Medipure Holdings Inc. (CSE:MDH) press release.

    cannabis investingpharmaceutical industrythe pharmaceutical industry
    The Conversation (0)

    Go Deeper

    AI Powered
    Person touching a cannabis plant; Australia map in flag colours.

    ASX Cannabis Stocks: 10 Biggest Companies

    A colorful brain illustrating brain on pyschedelics.

    Psychedelics Stocks to Watch

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Cannabis Investing News Stocks

    extractX

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×